<SUBMISSION>
<ACCESSION-NUMBER>0001104659-06-022486
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20060331
<ITEMS>3.02
<ITEMS>5.01
<ITEMS>5.02
<ITEMS>8.01
<ITEMS>9.01
<FILING-DATE>20060405
<DATE-OF-FILING-DATE-CHANGE>20060405
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CRDENTIA CORP
<CIK>0001073857
<ASSIGNED-SIC>7361
<IRS-NUMBER>760585701
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-31152
<FILM-NUMBER>06741867
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>14114 DALLAS PARKWAY
<STREET2>SUITE 600
<CITY>DALLAS
<STATE>TX
<ZIP>75254
<PHONE>972-850-0780
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>14114 DALLAS PARKWAY
<STREET2>SUITE 600
<CITY>DALLAS
<STATE>TX
<ZIP>75254
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>LIFEN INC
<DATE-CHANGED>20001115
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>DIGIVISION INTERNATIONAL LTD
<DATE-CHANGED>20001005
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a06-7963_38k.htm
<DESCRIPTION>CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<div style="border:none;border-top:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE
COMMISSION</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington,
DC&#160; 20549</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h2 align="center" style="color:black;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="5" color="black" face="Times New Roman" style="color:windowtext;font-size:18.0pt;">FORM&nbsp;8-K</font></b></h2>

<h2 align="center" style="color:black;font-size:10.0pt;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><font color="black" style="color:windowtext;font-weight:normal;">&nbsp;</font></h2>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of<br>
the Securities Exchange Act of 1934</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of
earliest event reported): &#160;<b><font style="font-weight:bold;">March&nbsp;31, 2006</font></b></font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">CRDENTIA CORP.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as
specified in its charter)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-31152</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">76-0585701</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or
  Other Jurisdiction of<br>
  Incorporation)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission
  File Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S.
  Employer<br>
  Identification Number)</font></p>
  </td>
 </tr>
</table>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="center" style="color:black;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;">5001
LBJ Freeway, Suite&nbsp;850<br>
Dallas, Texas 75244</font></b></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of Principal Executive
Offices) (Zip Code)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(972)
850-0780</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number,
including area code)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">14114
Dallas Parkway, Suite&nbsp;600<br>
Dallas, Texas 75254</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former address,
if changed since last report.)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (<i><font style="font-style:italic;">see</font></i> General
Instruction A.2. below):</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Written communications pursuant to Rule&nbsp;425 under the Securities Act (17
CFR 230.425)</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR
240.14a-12)</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the
Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the
Exchange Act (17 CFR 240.13e-4(c))</p>

<div style="border:none;border-bottom:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\06-7963-3\task1001043\7963-3-ba.htm',USER='nnarayanan',CD='Apr  5 23:52 2006' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 3.02</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font style="font-weight:bold;">Unregistered Sales of Equity
Securities.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Exchange of Series&nbsp;C
Preferred Stock and Warrants</font></i></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;3, 2006,
Crdentia Corp. exchanged 10,257,131 shares (as adjusted for the reverse stock
split discussed below under <i><font style="font-style:italic;">Item 8.01 &#150; Other Events</font></i>)
of common stock for all of its outstanding (i)&nbsp;shares of Series&nbsp;C
Preferred Stock, (ii)&nbsp;warrants to purchase shares of Series&nbsp;C
Preferred Stock, and (iii)&nbsp;warrants to purchase shares of Series&nbsp;B-1
Preferred Stock. In connection with this exchange, MedCap Partners LP was
issued 9,573,843 shares (as adjusted for the reverse split) of common stock. C.
Fred Toney, a member of Crdentia&#146;s Board of Directors, is the managing member
of MedCap Management&nbsp;&amp; Research LLC, the general partner of MedCap
Partners LP. In addition, 385,965 shares (as adjusted for the reverse split) of
common stock were issued to James D. Durham, Crdentia&#146;s Chairman and Chief
Executive Officer.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The shares
were issued in a private transaction pursuant to an exemption from registration
provided by the Securities Act of 1933, as amended.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;5, 2006
Crdentia Corp. issued a press release announcing the exchange. The press
release is filed with this report as Exhibit&nbsp;99.1.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">MedCap
Purchase</font></i></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;3,
2006 MedCap Partners LP purchased 58,333 shares (as adjusted for the reverse
split) of common stock at a price per share of $6.00 (as adjusted for the
reverse split). The shares were issued in a private transaction pursuant to an
exemption from registration provided by Section&nbsp;4(2)&nbsp;of the
Securities Act of 1933, as amended and/or Regulation D promulgated thereunder.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.01</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font style="font-weight:bold;">Changes in Control of Registrant.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Immediately following the
consummation of the transactions described above under <i><font style="font-style:italic;">Item 3.02 &#150;
Unregistered Sales of Equity Securities</font></i>, MedCap Partners LP
controlled approximately 77% of Crdentia&#146;s outstanding voting securities. As
consideration for the securities issued in the transactions described above,
MedCap Partners LP exchanged 173,438 shares of Series&nbsp;C Preferred Stock,
warrants to purchase 100,111 shares of Series&nbsp;C Preferred Stock and a
warrant to purchase 6,000 shares of Series&nbsp;B-1 Preferred Stock. The source
of funds used to purchase the Series&nbsp;C Preferred Stock and the warrants to
purchase Series&nbsp;C Preferred Stock and Series&nbsp;B-1 Preferred Stock was
working capital of MedCap Partners LP.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.02</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font style="font-weight:bold;">Departure of Directors or
Principal Officers; Election of Directors; Appointment of Principal Officers.</font></b></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;31,
2006, Joseph M. DeLuca resigned as a member of the Board of Directors of
Crdentia Corp.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;3,
2006 the Board of Directors of Crdentia Corp. elected William J. Nydam to the
Board and appointed him Chairman of the Audit Committee of the Board. Since
March&nbsp;2003, Mr.&nbsp;Nydam has served as president and chief operating
officer of Endocare,&nbsp;Inc., a publicly-traded medical device company. Mr.&nbsp;Nydam
also currently is a board member and the chairman of the audit committee
of&nbsp;iVOW&nbsp;,&nbsp;Inc. Prior to joining Endocare,&nbsp;Inc., Mr.&nbsp;Nydam
was president and chief executive officer of Pulse Metric,&nbsp;Inc., a
cardiovascular device company, from September&nbsp;2001 to December&nbsp;2002. Mr.&nbsp;Nydam
previously served as senior vice president for Science Applications
International Corporation, an employee-owned research and engineering firm,
from September&nbsp;1999 to August&nbsp;2001. Prior to that time, Mr.&nbsp;Nydam
worked for Premier,&nbsp;Inc., a national alliance of healthcare providers,
where he served as executive vice president from April&nbsp;1996 to August&nbsp;1999,
chief operating officer from May&nbsp;1992 to March&nbsp;1996 and senior vice
president and chief financial officer from January&nbsp;1986 to April&nbsp;1992.
Mr.&nbsp;Nydam holds a B.S. degree in accounting and an M.B.A. from the
University of California at Berkeley and he is a certified public accountant.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\nnarend\06-7963-3\task1001043\7963-3-ba.htm',USER='nnarayanan',CD='Apr  5 23:52 2006' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;3, 2006
Crdentia Corp. issued a press release announcing Mr Nydam&#146;s election and Mr.&nbsp;DeLuca&#146;s
resignation. The press release is filed with this report as Exhibit&nbsp;99.2.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item
8.01</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font style="font-weight:bold;">Other Events</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective as of 5:00&nbsp;p.m.
Eastern Time on April&nbsp;4, 2006, Crdentia implemented a one-for-ten reverse
split of its outstanding shares of common stock. At Crdentia&#146;s Annual Meeting
of Stockholders held on November&nbsp;8, 2005, its stockholders approved a
proposal to amend its Amended and Restated Certificate of Incorporation (the &#147;Existing
Certificate&#148;) to effect a reverse stock split of all of its outstanding shares
of common stock at an exchange ratio ranging from one-to-two to one-to-ten,
with the final ratio to be determined by the Board of Directors following
stockholder approval. Pursuant to a resolution of the Board of Directors
effective as of March&nbsp;1, 2006, the directors approved an amendment to the
Existing Certificate to effect a reverse stock split at an exchange ratio of
one-to-ten. No fractional shares will be issued in connection with the reverse
stock split. In lieu of fractional shares, stockholders will receive a cash
payment based on the market price, after adjustment for the effect of the stock
combination, of Crdentia&#146;s common stock on the effective date of the stock
combination. The reverse stock split also affects options, warrants and other
securities convertible into or exchangeable for shares of Crdentia&#146;s common
stock that were issued and outstanding immediately prior to the effective time
of the stock combination.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Beginning on April&nbsp;5,
2006, Crdentia&#146;s common stock will be quoted on the OTC Bulletin Board with the
ticker symbol &#147;CRDT.&#148;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of the Certificate of
Amendment to the Existing Certificate filed with the Delaware Secretary of
State on March&nbsp;20, 2006, and copies of the Certificates of Correction of
the Certificate of Amendment filed with the Delaware Secretary of State on March&nbsp;30,
2006 and April&nbsp;3, 2006, respectively, which documents effect the stock
combination, are attached hereto as Exhibits 4.1, 4.2 and 4.3, respectively.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;5, 2006
Crdentia Corp. issued a press release announcing the reverse stock split. The
press release is filed with this report as Exhibit&nbsp;99.1.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Financial
Statements and Exhibits.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&nbsp; <i><font style="font-style:italic;">Exhibits.</font></i></font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="95%" style="border-collapse:collapse;margin-left:.25in;width:95.0%;">
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1(1)</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Amendment of Amended and
  Restated Certificate of Incorporation of Crdentia Corp.</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2(1)</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Correction of Certificate of
  Amendment of Amended and Restated Certificate of Incorporation of Crdentia
  Corp.</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3(1)</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Correction of Certificate of
  Amendment of Amended and Restated Certificate of Incorporation of Crdentia
  Corp.</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press release of Crdentia Corp., dated April&nbsp;5,
  2006.</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.2</font></p>
  </td>
  <td width="92%" valign="top" style="padding:0in 0in 0in 0in;width:92.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press release of Crdentia Corp., dated April&nbsp;3,
  2006.</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)&nbsp;Previously filed on
Form&nbsp;SB-2 with the SEC on April&nbsp;4, 2006 and incorporated herein by
reference.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\nnarend\06-7963-3\task1001043\7963-3-ba.htm',USER='nnarayanan',CD='Apr  5 23:52 2006' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SIGNATURES</font></p><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p><p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="1%" valign="top" style="padding:0in 0in 0in 0in;width:1.5%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="48%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:48.5%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CRDENTIA CORP.</font></p></td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></td>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.7%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></td>
  <td width="46%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:46.3%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></td>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.7%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></td>
  <td width="46%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:46.3%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;5, 2006</font></p></td>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.7%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p></td>
  <td width="26%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.86%;"><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ James J. Terbeest</font></p></td>
  <td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.44%;"><p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:1.0pt;font-style:italic;">&nbsp;</font></i></p></td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.7%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.86%;"><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">James J. TerBeest</font></p></td>
  <td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.44%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.7%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="26%" valign="top" style="padding:0in 0in 0in 0in;width:26.86%;"><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer</font></p></td>
  <td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.44%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
 </tr>
 <tr height="0">
  <td width="374" style="border:none;"></td>
  <td width="11" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="201" style="border:none;"></td>
  <td width="145" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\nnarend\06-7963-3\task1001043\7963-3-ba.htm',USER='nnarayanan',CD='Apr  5 23:52 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a06-7963_3ex99d1.htm
<DESCRIPTION>EXHIBIT 99
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.1</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.64%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NEWS BULLETIN</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.56%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.64%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FROM:</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.56%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.64%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="204" height="81" src="g79633mmi001.jpg"></font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.56%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RE:</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.86%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Crdentia Corp.<br>
  14114 Dallas Parkway,<br>
  Suite&nbsp;600<br>
  Dallas, TX 75254<br>
  OTCBB: CRDE</font></b></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.4%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For Further
  Information:</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.96%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.4%;">
  <p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AT THE
  COMPANY:</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.96%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AT FINANCIAL RELATIONS BOARD:</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.4%;">
  <p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">James D. Durham</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.96%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lasse Glassen</font></p>
  </td>
 </tr>
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.4%;">
  <p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman and CEO</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.96%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">310-854-8313</font></p>
  </td>
 </tr>
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.4%;">
  <p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">972-850-0780</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.96%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">lglassen@financialrelationsboard.com</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">April&nbsp;5, 2006</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CRDENTIA SUBSTANTIALLY ENHANCES CAPITAL STRUCTURE
WITH ELIMINATION OF PREFERRED STOCK OUTSTANDING AND 10-FOR-1 REVERSE STOCK
SPLIT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Common Stock will trade under
symbol CRDT.OB</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Company eliminates all issued and outstanding preferred stock</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">and warrants to purchase preferred stock</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Company effects reverse stock split previously approved by</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Shareholders</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DALLAS &#150; April&nbsp;5,
2006 &#150; Crdentia Corp. (OTCBB: CRDT.OB)</font></b>, a leading U.S. provider of healthcare
staffing services, today announced that an independent Special Committee of the
Board of Directors has evaluated and approved the exchange of the Company&#146;s
outstanding Series&nbsp;C Preferred Stock, along with the exchange of Warrants
to purchase Series&nbsp;C Preferred Stock and Warrants to purchase Series&nbsp;B-1
Preferred Stock (together, the &#147;Warrants&#148;) for shares of the Company&#146;s Common
Stock. All holders of the Preferred Stock and Warrants have reviewed and
accepted the exchange offer.</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to the exchange offer, holders of Series&nbsp;C Preferred Stock will receive
500 shares of Common Stock for each share of Series&nbsp;C Preferred Stock. In
addition, holders of the Warrants will receive 85 shares of Common Stock for
each Warrant.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Simultaneously
with the exchange offer, the Company has effected a 10-for-1 reverse split of
the Company&#146;s Common Stock. The Company&#146;s Common Stock will now trade under the
symbol <i><font style="font-style:italic;">CRDT.OB </font></i>effective immediately. The
Company&#146;s stockholders approved the reverse split at the Annual Meeting of
Stockholders held on November&nbsp;8, 2005 and the Company&#146;s Board of Directors
approved the reverse Split on March&nbsp;1, 2006, subject to the timing and
completion of the exchange offer. Subsequent to the exchange offer and reverse
split, there are approximately 14.0 million shares of Common Stock outstanding
and there are no shares of Preferred</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">- more -</font></i></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Financial
Relations Board serves as financial relations counsel to this company, is
acting on the company&#146;s behalf in issuing this bulletin and receiving
compensation therefor. The information contained herein is furnished for
information purposes only and is not to be construed as an offer to buy or sell
securities.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\smani\06-7963-3\task1001186\7963-3-mm.htm',USER='smani',CD='Apr  6 00:23 2006' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock outstanding and no Warrants to purchase Preferred
Stock outstanding, eliminating liquidation preferences and dividends associated
with the Preferred Stock and Warrants.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Commenting on
today&#146;s announcement, James D. Durham, Chairman and CEO of Crdentia, said, &#147;I
believe the exchange offer and reverse stock split are in the best long-term
interests of the Company and its stockholders for several important reasons. First,
the exchange offer eliminates substantial liquidation preferences that
previously accrued to holders of the Series&nbsp;C Preferred Stock and provides
immediate value to holders of Crdentia Common Stock by virtue of this
elimination. In addition, the exchange offer simplifies the Company&#146;s capital
structure, making our Common Stock significantly more appealing to new
investors and potentially for use in any future acquisitions. And finally, both
the exchange offer and reverse split improve Crdentia&#146;s ability to list its
Common Stock on a national market exchange such as Nasdaq, thus potentially
providing better liquidity for the Company&#146;s stockholders. We intend to
promptly begin applying for such a listing.&#148;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company has
agreed to register the shares of Common Stock on a suitable form&nbsp;and
substantially in compliance with the existing Registration Rights Agreement
covering the Series&nbsp;Preferred C Stock and Series&nbsp;C Warrants within 60
days of completion of the exchange offer.</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Crdentia Corp.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;Crdentia Corp. is one of the nation&#146;s leading
providers of healthcare staffing services. Crdentia seeks to capitalize on an
opportunity that currently exists in the healthcare industry by targeting the
critical nursing shortage issue. There are many small, private companies that
are addressing the rapidly expanding needs of the healthcare industry. Unfortunately,
due to their relatively small capitalization, they are unable to maximize their
potential, obtain outside capital or expand. By consolidating well-run small
private companies into a larger public entity, Crdentia intends to facilitate
access to capital, the acquisition of technology, and expanded distribution
that, in turn, drive internal growth. For more information, visit
www.crdentia.com.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Forward Looking Statements</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Statements contained in this release that are not
historical facts are forward-looking statements that involve risks and uncertainties.
Among the important factors which could cause actual results to differ
materially from those in the forward-looking statements include, but are not
limited to, those discussed in &#147;Risk Factors&#148; in the Company&#146;s Forms 10-KSB,
Forms 10-QSB, and other filings with the Securities and Exchange Commission. Such
risk factors include, but are not limited to, a limited operating history with
no earnings; reliance on the Company&#146;s management team, members of which have
other business interests; the ability to successfully implement the Company&#146;s
business plan; the ability to continue as a going concern; the ability to fund
the Company&#146;s business and acquisition strategy; the growth of the temporary
healthcare professional staffing business; difficulty in managing operations of
acquired businesses; uncertainty in government regulation of the healthcare
industry; and the limited public market for the Company&#146;s common stock. The
actual results that the Company achieves may&nbsp;differ materially from any
forward-looking statements due to such risks and uncertainties. We undertake no
obligation to revise or update publicly any forward-looking statements for any
reason.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\smani\06-7963-3\task1001186\7963-3-mm.htm',USER='smani',CD='Apr  6 00:23 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>a06-7963_3ex99d2.htm
<DESCRIPTION>EXHIBIT 99
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.2</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.16%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NEWS BULLETIN</font></b></p>
  </td>
  <td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.32%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RE:</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.68%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Crdentia
  Corp.</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.16%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FROM:</font></p>
  </td>
  <td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.32%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.68%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">14114
  Dallas Parkway,</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="34%" rowspan="3" valign="top" style="padding:0in 0in 0in 0in;width:34.16%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="195" height="44" src="g79633moi001.jpg"></font></p>
  </td>
  <td width="22%" rowspan="3" valign="top" style="padding:0in 0in 0in 0in;width:22.32%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.68%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Suite
  600</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.68%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Dallas,
  TX 75254</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.68%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OTCBB:
  CRDE</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="56%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:56.48%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.68%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For Further Information:</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.96%;">
  <p style="margin:0in 0in .0001pt .65in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AT THE
  COMPANY:</font></b></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.04%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AT FINANCIAL RELATIONS</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.96%;">
  <p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">James D. Durham</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.04%;">
  <p style="margin:0in 0in .0001pt 10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BOARD:</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.96%;">
  <p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chairman and CEO</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.04%;">
  <p style="margin:0in 0in .0001pt 10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lasse Glassen</font></p>
  </td>
 </tr>
 <tr>
  <td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.96%;">
  <p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">972-850-0780</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.04%;">
  <p style="margin:0in 0in .0001pt 10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">310-854-8313</font></p>
  </td>
 </tr>
 <tr>
  <td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.96%;">
  <p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.04%;">
  <p style="margin:0in 0in .0001pt 10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">lglassen@financialrelationsboard.com</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt 4.5pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">April 3, 2006</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CRDENTIA </font></b><b><font style="font-weight:bold;">ANNOUNCES APPOINTMENT OF WILLIAM
NYDAM TO BOARD OF DIRECTORS</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Nydam Elected Chairman of Company&#146;s Audit Committee</font></i></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DALLAS &#150; April 3, 2006 &#150; Crdentia Corp.
(OTCBB: CRDE)</font></b>, a leading U.S. provider of healthcare
staffing services, today announced the unanimous election of William J. Nydam
to the Company&#146;s Board of Directors, effective April 3, 2006. Mr. Nydam will
also chair Crdentia&#146;s audit committee.</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;We are delighted to
attract a man of Bill&#146;s stature and expertise to our Board of Directors at this
very exciting time in the development of the Company,&#148; said James D. Durham,
Crdentia&#146;s Chairman and CEO. &#147;Bill&#146;s decades of leadership as a seasoned executive
and hands-on experience in healthcare-related businesses will be invaluable in
helping Crdentia position itself for its next phase of growth.&#148;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Nydam is currently
President and Chief Operating Officer of Endocare, Inc., a publicly-traded medical
device company. Prior to joining Endocare, Inc., Mr.&nbsp;Nydam was President
and Chief Executive Officer of Pulse Metric, Inc., a cardiovascular device
company, from September 2001 to December 2002. Mr.&nbsp;Nydam previously served
as Senior Vice President for Science Applications International Corporation, an
employee-owned research and engineering firm, from September 1999 to August
2001. Prior to that time, Mr.&nbsp;Nydam worked for Premier, Inc., a national
alliance of healthcare providers, where he served as Executive Vice President
from April 1996 to August 1999, Chief Operating Officer from May 1992 to March
1996 and Senior Vice President and Chief Financial Officer from January 1986 to
April 1992. Mr.&nbsp;Nydam holds a B.S. degree in accounting and an M.B.A. from
the University of California at Berkeley and is a certified public accountant.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Nydam replaces the
position of former director, Joseph M. DeLuca, who resigned his position on
March 31, 2006 after the completion and filing of the Company&#146;s Annual Report
on </font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">-more-</font></i></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Financial Relations Board
serves as financial relations counsel to this company, is acting on the
company&#146;s behalf in issuing this bulletin and receiving compensation
therefor.The information contained herein is furnished for information purposes
only and is not to be construed as an offer to buy or sell securities.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\smani\06-7963-3\task1000648\7963-3-mo.htm',USER='smani',CD='Apr  5 21:46 2006' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form 10-K, to pursue
other interests. The Company thanks Mr. DeLuca for his valued service as a
board member for Crdentia and wishes him the best in his new endeavors.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Crdentia Corp.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Crdentia Corp. is one of
the nation&#146;s leading providers of healthcare staffing services. Crdentia seeks
to capitalize on an opportunity that currently exists in the healthcare
industry by targeting the critical nursing shortage issue. There are many
small, private companies that are addressing the rapidly expanding needs of the
healthcare industry. Unfortunately, due to their relatively small
capitalization, they are unable to maximize their potential, obtain outside
capital or expand. By consolidating well-run small private companies into a
larger public entity, Crdentia intends to facilitate access to capital, the
acquisition of technology, and expanded distribution that, in turn, drive
internal growth. For more information, visit www.crdentia.com.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="2" width="100%" noshade color="gray" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\smani\06-7963-3\task1000648\7963-3-mo.htm',USER='smani',CD='Apr  5 21:46 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g79633moi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g79633moi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"``L`,,#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBD(!!!
MZ&@!:3.:XO3X8/[=UB&2PGNXXI5$:QMD1C'3EAUKHO#\42:3')%!);B=FE,3
ML24)/3FF*YIT5S'B:&,ZWHO!_?W!27#$;UP.#73*H50H&`!@"D,6BN1FMM0M
M?$5]/H[9^SQQ,]HQ.V8$'./0\<5(+VPUK6-*GA4AG:59XF)#*RKP&'L:=A7.
MJHHKB-9U-KZZDU"TOA&=-D_T:'G]^1]\GV/0?0T`V=O1573;^'4]/AO(#E)5
MSCT/<?@:RO%MJLVGQ.KM%,;B*-94)#*"P'%(9OT5RSZE+%;SZ/KP`N1$QM[C
MHEQ@<$'LWM6QH$:1Z%9E1@O"KL<YR2!DTQ7-&DKF+!F\0ZWJ*7LKBWLI/+CM
M5<J#U^9L<GI]*U#X>TX7$$\,30/!(''EN0&QV(Z&@#4HJ.:))H6CD4,C#D'O
M7/>!D#:/),V6D,[J68DG`/`I#.EHJO?7L.GV4MW.<1Q+DXZGT`]S7'6FK-IN
ML0:A<7RRIJ/RW48)Q;M_!CV`X_.G85SN:*2N8UZ",^*M'4J=L[/YH#$!\`8S
M2&=112`8&!2T`%%%%`!2'D$`X/K2TA&01Z^E`&9I^BC3[^XO%O)I'NCNE5PN
M&(Z=!Q6I7G<FIW$$.KJ]SJ7F1WS6]I.)R(XCQM#DG`&>Y%;/B:74+3P_ILKW
M4HO//ABF:VD*"3=]X#MS72Z#32ON<RKIINVQL:CHHU*\M[E[N6-K5M\2H%PK
M>O(YK24$*`3D@=?6L/3[=Y+^[\R/4;=%A5%$]R6#YR25P3@C&.#WJ/P5/-<^
M'([JZN)9I9)'#/*Y;HQ`Z].*S=.T6[[6_$T52\DK;W_`T;?2V@U*:^^URNTP
M`="JX(&<=!VS37T.S;6HM613'<H"&V]),C'/O6%XCU:^FO)(]*FE3^S<2,$B
M9A<2]XB0,8"YS[D>E:MNMMK]O!J\-Y=I')!@113%`#G)SCN#Q^%-TFHJ3ZB5
M5.3BNAI7MLUY:O`MQ)!O&"\>-V/;-)968LK".SCD)6-=JMM`(';@#%<YX4M)
M=5T"RO[K4;YI_,9F/VAL/AB,$=,8K.&L:AIVDZM<1W,LDB:H;2.6=RZP1Y'S
M8/I_6J]@W)Q3U1/MTHJ36C.ITG1%T<RB&ZE>*5BYB8+M#'N,#CZ5-J>F_P!I
MQQQM<R1+&X?"!>6!R.H]JSM0TU['2)[R'5[Q+B"(R">6;<K$#/*GY<'V%9(O
MM;U"72;ZPD,-S<6;W$MK(Q\J4J5&W!^[D$D&E&ES:ICE5Y=&CJ-0TJVU33S9
MWJ^:I'W\`,#_`'AZ&I[.V6SLX;9&++"@0$]3@8KG-.U=-7\30".2Y@9+9S<6
M;R$>5(K*`"O3H3[&J-U-?60N)=9GOO(>8M'J-C.3%&F[A6C'0=B<&FJ+O9L3
MK*UTCI+K0[:XO?MT,DMI=XP9H&P7'HP.0?Q%']DS23PRW6IW$X@<.J`*BDCU
MP.:T/DGA^5B4D7AE..#W!KSV&]U4^'+F^CGU`RP73C[49]T<:*_.Y"<L`/:I
MITW/J54J*'0]"E1I(F1)#&Q'#@`D?G5#1M'318&@AN)9(F8MMD`X)ZG(%9,=
M_/K7B5M.^VO!9PVL<Z&`[&N=P^]GJ%'H*?=3W&B>(],M+>ZFN;>_++);S/O:
M/`SO5CSCUS1[)[7UM</:K>VE[&KJ.E?VC+`SW4L:P.)%C4*5+#H3D<U)JFG)
MJM@]G+(R1R?>*@$G\^E<IJ/B*[74?[8MI9CI]I+Y1MUB<K-%T>7=C'!Z>P/K
M6EXQO)$\/17UC=2H6FBV/!(5W*Q'YY%/V$KQ3ZB]O&TFNAN6%JUE:);M<23A
M!A6DQNQV'`YJG?Z(+_48+YKV:.2VSY00+A<CGJ.:RM'N[FX\4S0VTUU':6T6
MVYM[V3<^\_=*@DG'OG%)I<,M]XAURUFOKT16LD8A5;EALW+D]_6ATK7N]E<%
M5O:RW=C=@TZ6.\6YFU"XG*H4"-M"\XYP`,GBKU<]H.H7;:UJ>D3SF\BLBACN
M2!N^8?<8C@D>M=#6<XN+LS2$E)704445!84A&01ZTM%`&=!H&F6\=S&EME+O
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M]*-Y\2[482,`H],9QC@?E5NBCGD^H*$5T*W]GV@U'^T!`HNC'Y9E'!*YS@^O
M2J7_``C.D[/*-NYA+%S"9G,9).<E<X/-:U%"G);,'"+W0UD5HS'R%(Q\IQ@>
MV.E92^%]'6!H!;/Y+,6:(S.48GDDC.#6O10I2CLP<8O=%*ZTBPO!%YUNNZ`8
MB="4:,>@(P0*C30=.C$I$+-),NQY6E9I"OIN)R!]#6C11SRM:X<D;WL5$TRT
MCTW^SDC86VS9LWMPOIG.<56;PWI36$=@UNYM8FW)%YSX4]N_:M2BA3DMF#A%
M]"C+H]C-<PW+PG[1`NQ)A(P?;Z$@Y(^M0CPYI@GFG$4JR3G,K+<2`O\`7#5J
K44^>2ZBY(OH5[.QM=/@$%I`D,><[4&,GU/J:L445+;>K*22T04444AG_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g79633mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g79633mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!1`,P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HJ
M`WMH#@W4/'_304L-W;W#ND$\<C1XWA&SMSTH`FHJ.2>&''FRI'GIN8#-+')'
M*N^-U=?53D4`/HJ,SPB41&5!(?X"PS^5+)+'"NZ6147.,L<"@!]%,CDCE7=&
MZNOJIR*=0`M%,BFCGB66&19$;HRG(-.)`!).`.]`"T5'%-%,"8I4D`Z[6!Q2
M/=6\;['GC5O[K.`:`):**AGN[:U`-Q<10@]/,<+G\Z`)J*ABN[>=]D4\<C;=
MV$8'CUI\DT4(!EE2,'H68#-`#Z*9'+',NZ*177.,J<BGT`%%,CFCE+B.17*-
MM;:<[3Z'WI]`!14+W=M&Y1[B)6'4,X!%2]1D4`+1110`4444`<=#I&G7'CJ_
MMY;*%X5ME<(4&`QQD_6MO1;"PM)[V73BHB>01M$B;1&R#!'OUK%DTVUU3QY?
M172NRK:HPVN5YX]*W]%TH:1:RVZ/N1IGD3KE0>@)/7ZTV)&;XY@AD\-3RO$C
M21%=C$<KEAG%;&F6\-MIL$<$21IY8.U!@9(Y-9?C;_D5;OZI_P"A"MBR_P"/
M&W_ZY+_*CH'4YKQK8&1K&XLHE6_,_P`DBC#'"D@9_"IWU"V\0^#+FYEB1I(X
M'WHPSY<@4\^WJ*N:Y_R$-&_Z_/\`V1JY_P`1PR>';R[NH$)L=4A>.5!T20@X
M/^?>A".LT>"&WTBU2&)(U,2L0HP"2!DU#XANWL]&F,7^NEQ#$/5F.!_//X59
MTW_D%VG_`%P3_P!!%8VM_;;_`%ZSL]/\@O9K]I?SL[,GY5SCOU-'4?09X+>2
MVM[S1IVS+83%1[J>0?SS^==*RAE*L`01@@]ZXZ,ZCI7C.WN=2%NHU)#"QM\[
M<C&,Y[]*[&A@C@Q<_P#"-^++NXAA6/3&E2&94&`A*@@X_/\`6MS5;*RN/$ND
M2/;PR&42EF*@[\*-OUQVH@L8=2OO$%G<+F.62,'V^08(^E8VBW%U%XAT_1KX
M$S:>9E5_[Z%/E_E3$=?JM\NF:7<7K#=Y*%@/4]A^=8>@Z%;W]DFJZO&MY>78
M\PF49"*>@`Z#BM+Q-:27OAV]@B!+F/<H'?!SC]*;X6OHK[P]:-&PW1QB-Q_=
M91BET'U#3?#]MI6JW%W9JL4,\:KY('`8$DD>WM47C""&;PU=O)$CM$FY"PR5
M.1R*UA=0M>-:!_WRH)"N/X22`?T-9OBS_D5[_P#ZY?U%`=";P]!#!H5F(8DC
M#PJS;1C)(&3]:MWETEE9374APD*%S^`JOH?_`"`K'_KW3^0JAXJ,UU!;:3:[
M3->R\A\[=B_,<X[=!1U#H9?A*6ZLM9N+.^/SW\2WB_4]1^OZ5V5<3K0UC3[_
M`$_6K];,);2B-OLV[.UNN<]NOYUVH(8`@Y!Y!H8(Y/Q!8VDGB_1]]M$WGE_-
MR@._`&,^M=8````,`=!7-:[_`,CAH/UD_E71-/$DR0M(HDD!**3RV.N*&")*
M***0PHHHH`Q+?PX8-7.I_P!IW3S-PX;;AE[*>.E;=8S^+O#\<C1OJL"LIPP)
M(P?RJ[=:MI]E9)>W%W&EL^-LN<J<].15N$^J(4X=&0ZUHRZU;"VDNYH8OXUC
MQA^F,Y';%6;"T:RM$MVN)+C9T>3&<>G%4;?Q5H=W=16UMJ$<TTS;45`3DXSZ
M>U36FOZ5?7AL[6]CEN%SF-<Y&.M#IS6Z!5(/9D>IZ(VI74,_]HW-OY)W(L>W
M`;GYN1UP:M:AIL.IZ;)8W.621<;NX/8_6K$LJ0Q/+(P5$4LS'L!UJI-K-A!I
M2ZK).!9LJL)0"1AL8/ZTDF]AMI;EFWA%O;10`EA&@0$]\#%9]EH9LM3FO_[0
MN9FG_P!8C[<-CIT';M4/_"9^'/\`H+V_YG_"G#Q;H/EQ.=1C43`F/<"-PR1Q
MQZ@U7LJG\K^XGVM/^9?>.UGP^NLS0O)>W$(A(9%CVX##^+D9S6G#&T4"1M*T
MC*H!D;&6]S574=:TW241K^\C@W_=#'EOH!S0FM:;)IIU%+R)[1?O2J<@?6IY
M96O8KFC>UR#3M$:POI;O^T;F<S<R))MPQQ@'@=A4T^DV\VKVVI\K/`K)Q_&"
M.A^E2QZG92Z=_:,=RCVNTMYJG(P.M16^MZ9=6,M]#>Q-;0_?ESA5_$T<LNP<
MT>Y?K"G\+0B\DN]-O;C3993F00$;&_X">*MZ=XATK5IV@L+Q9Y%7>RJI&!G&
M>14VH:K8:3&LE_<I;HYPK/T)I\DD^6VHN:+5[Z%?2M"CTRXFN6N[B[N9@%>6
M9L\#H`.U2:QI0UBT^RO=301M]\1X^<>AR*-/U[2M5D:*QOX9Y%&2BMSCUQ1J
M.NZ7I#(M_>Q0,_*J3EB/7`YQ1R3YK6U#GARWOH2:98'3;);7[3+<*G"M+C*C
M&`.!TJM+H9EUI-3_`+0N5=.%C&W:%XRO3H<5?M;NWOK=;BUF2:%QE71L@TU+
MZVDOI;%)0;B)%=X^X!Z']*FS*NBMK.D+K5H+62YEAB)^=8\?/Z9R*GTZS:PL
MTMC<2W&S@/+C..PXJ+4-<TS29$CO[R.W9QE0^>13M/UC3M55VL+R*X$?W]C<
MK]13Y96O;07-&]KZE'4?#?\`:.HI>MJ5W$\7^J$94"/C!QQWI]GH#6VH17LV
MIW=V\2LJ+,00,]>@]J:?&/AU6*MJUNI!P021C]*UH9HKB%9H)%DC<95T.01[
M&G*,H[JPHRC+9W)****@L****`."DUC3M)\4^(O[15G681*B"(OO.SITP,Y[
MU8CL+K3OA9=6]XACE%O(WEGJ@))`_*EBTFXU36->AO=-N8+74D01ROMPI08!
MX/KR*=(VN3>#;K2;S2KF2]6(VZR(5*RCD!LY]`,UZ+:]U)_RWU\OZN><D]6U
M_-;3S_JQ+H^JV=_)HNGFPG#QP>:LLT31@,B`97^]]XU/H?\`R.WB/_MA_P"@
M&FZ?>:GLTNU_L&XA:`)%+<3!"%3;AL8;(S@56LI]3L/$FKWYT&^EBO#&(]I3
M/RC!)RW>LVK\R7;OYFB=N5OOV\C5\5RAM.BTX2"-M1F6`L3C:G5S_P!\@_G6
M=X3B@NM*N]!N\3+IMT47YOO)NW(>/\\4RUM[W7]8@;Q!HD@@B@=4$BJ8PY;.
M2,G^$*/KFG6NGRZ-XT9]-TB5-.GA6*8QA0@?.0P&>G8_C0DE!POKO\_7T"[E
M-5+:;?+T]27RH_\`A9.WRUQ_9G3:/[],URT@L=8\-6]O'LC%[(P7/<C)_4FE
M_P!/_P"$[_M#^R;O[-]F^R^9\F,[\[OO?=Q^/M4GB9+V76](EMM-N;B.RF,L
MCQ[<8(Q@9(YH3]^.O3]&#^"6G7]41^%474]9UC6+E0\RW1MHMW/EHO8>F::R
M+I7Q`$%L`D&IVC/+&!\N]<_-CUQ4@M[_`,-:Q>75I82W^GW[^:T<!'F0R=^"
M1D&EL[2_N-4N?$FH64D;I!Y-I9*0T@7J2><;CZ9H;5W*^C5OZ]`2=E&VJ=_Z
M]3(\'W4N@S6EI<N38:NGF6[GI'-W3\:L2Z=>:E\.K2.Q02S12>=Y)Z2A7)V_
MY]*N6NB2:MX*CTN\MI;.Y@'[II,960<AA@GCG'YTMHFM:5X1TM(+226[AE'V
MB!2`63+;N3QZ<U<IIRYEO?\`SU(C!J/*]K?Y:$_AW5],UV]:[2)[;4X(?)FM
MY."JYST[C/>E\>_\B=>_\`_]#%5]/M;K4_%RZV^F2Z=##;F(^=@/,Q/H#T`[
MU:\:P7=YX=ELK.SEN99RH'EXPN"#DY(]*RM%5HV\OD:^\Z,K^?S,B.[BU+QE
MI#I;36#6T#DFYB\MKC(QM4=\=:N>"(UU""]UNY4275W<NNYADHBG`4>@ILT6
MIZ[JND;M*FL(-/E\Z2:=URV!C:H!/6G6L.H>%+N[A@TV;4--N93-#]G(WPL>
MJD$CCWJY-.'*M[=_-]?Q(BFI<SVOV\ET_`33=FD>.]0T^'$=I<VPNS&.%C<'
M!(],UE6%T8/$MCX@:<%-8ED@=-P^1<_NN/\`@(JU=:?K+PZEJTEA*;_4D%O%
M!"RL;:'ODY')'IWJ77O"]D/#H?2=$,=_\AB\M%$B,.?F.?;!JTX7U>^GX?U]
MQ#4[:+;7\?Z^\L>.94@31II<[(]2C9L*6.`#V'6HM$ECUCQG<:SIL3)8):^0
M\I38)I,YZ'G@4:Z^J:C;Z+*NC79EM[E+B=1L^7;D$?>ZGJ*GMK2_T3Q)--:6
M,LVFZF!)(B%<V\O<D$]#WQ_2H5E2MUL^OF6[NK?I==/(3P[%'+XD\2K)&CC[
M3&,,H/\`":9X>0:5XNU71(.+,HMS%'VB)Z@>@YJOIMQJ^FZQJ]V/#U[*M],K
MQC?&N,#'/S5K>'M(O+>[O-7U38+^^(S&ARL*#HN>]*;LI7>C2^_0<%?ELM4W
M]VIO4445Q':%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
944`%%%%`!1110`4444`%%%%`!1110!__V3\_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
